North America Hospital at Home Market Analysis and Forecast by Size, Share, Growth, Trends 2034

The North America Hospital at Home Market size is expected to reach US$ 33,857.1 Million by 2034 from US$ 17,061.3 Million in 2025. The market is estimated to record a CAGR of 8.0% from 2026 to 2034.

Executive Summary and North America Hospital at Home Market Analysis:

In North America, the hospital at home market is segmented into the US, Canada, and Mexico. In the region, the Hospital at Home (HaH) model has witnessed substantial adoption as a means to deliver acute inpatient-level care in patients' homes, supported by regulatory frameworks and demonstrated clinical benefits. The Centers for Medicare and Medicaid Services (CMS) launched the Acute Hospital Care at Home (AHCaH) program in November 2020, enabling participating hospitals to provide hospital-level services at home under Medicare fee-for-service, with waivers granted to nearly 400 hospitals. Key examples include Presbyterian Healthcare Services, which tripled at-home admissions during the COVID-19 pandemic, reducing risks of delirium, falls, and infections while freeing hospital beds; Mount Sinai Health System, which expanded its Hospitalization at Home program to include non-COVID and low- to medium-acuity COVID patients; Atrium Health, which implemented a virtual hospital to support recovery at home and limit disease spread; and Brigham Health, where patients receive hospital-level monitoring with fewer clinical interventions, increased physical activity, comparable satisfaction, and reduced readmissions. Evidence from implementations shows HaH programs lower complication rates, improve patient mobility and experience, and decrease readmissions compared to traditional inpatient care. These programs have proven effective in managing conditions such as respiratory issues, heart failure, and infections, enhancing outcomes while aligning with patient preferences for home-based recovery.

North America Hospital at Home Market: Strategic Insights

North America Hospital at Home Market Segmentation Analysis:

• By Component, the North America Hospital at Home Market is segmented into Equipment and Devices and Software and Services. The Software and Services segment dominated the market in 2025.
• By Service Type, the North America Hospital at Home Market is segmented into Acute Care at Home, Chronic Disease Management at Home, Post Acute or Transitional Care, Palliative Care and Hospice Care, and Rehabilitation Services. The Palliative Care and Hospice Care segment dominated the market in 2025.
• By Delivery Mode, the North America Hospital at Home Market is segmented into Remote Monitoring and Telehealth, In-person Home Visits, and Hybrid Models. The Remote Monitoring and Telehealth segment dominated the market in 2025.
• By Patient Demographic, the North America Hospital at Home Market is segmented into Adult Patients and Pediatric Patients. The Adult Patients segment dominated the market in 2025.
• By Indication, the North America Hospital at Home Market is segmented into Cardiovascular Conditions, Respiratory Diseases, Orthopedic and Post-Surgical Recovery, Infectious Diseases, Neurological Rehabilitation, and Others. The Neurological Rehabilitation segment dominated the market in 2025.
• By Care Provider, the North America Hospital at Home Market is segmented into Hospitals and Health Systems, Home Health Agencies, Primary Care or Physician Groups, and Private HaH Providers. The Hospitals and Health Systems segment dominated the market in 2025.

North America Hospital at Home Market Players Density: Understanding Its Impact on Business Dynamics

The North America Hospital at Home Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

North America Hospital at Home Market Outlook

According to the World Health Organization, globally, the number of people aged 60 and above is projected to increase from 1.1 billion in 2023 to 1.4 billion by 2030. The global median age stood at 31.1 years in 2026, and projections indicate that the share of people aged 65 and above is expected to reach 20.74% by 2074. This demographic shift places substantial pressure on healthcare systems, as older adults require increased spending on pensions, healthcare, and long-term care.

Elderly patients often suffer from multimorbidity-having two or more chronic diseases-which makes traditional hospitalization risky due to complications such as delirium, falls, or infections. Hospital at Home (HaH) models address this concern by delivering acute-level care in the patients' home, preserving familiarity and reducing hospital-acquired issues. Geriatric-focused HaH programs across the globe target acute illnesses in older adults, offering comprehensive assessments and monitoring while maintaining independence. In France, the long-established hospitalization a domicile (HAD) system supports complex care for elderly patients with chronic conditions, accounting for a notable portion of alternative bed days. Similarly, studies on older home care recipients highlight high rates of neurological conditions and dementia, underscoring HaH's role in managing these vulnerabilities. This factor positions HaH as an essential component of sustainable geriatric care amid growing demographic pressures.

North America Hospital at Home Market Country Insights

By country, the North America Hospital at Home Market is segmented into the United States, Canada, and Mexico. The United States held the largest share in 2025.

In the US, the Hospital at Home (HaH) model has expanded significantly under the Centers for Medicare and Medicaid Services (CMS) Acute Hospital Care at Home (AHCaH) initiative. Launched in November 2020 during the COVID-19 public health emergency, the program delivers acute inpatient-level care in patients' homes for Medicare beneficiaries. As of mid-2025, approximately 400 hospitals across more than 140 health systems were approved to participate. Recent legislative efforts include a House-passed bill in December 2025 (H.R. 4313) and ongoing extensions in spending proposals, aiming to continue waivers through 2030 and allowing hospitals to waive certain facility requirements while maintaining safety standards. Key examples include Mount Sinai Health System's program, which treats conditions such as heart failure and infections with remote monitoring and in-person visits, resulting in reduced complications such as delirium and falls; Mayo Clinic's collaborations for post-acute transitions; and numerous rural and urban hospitals leveraging the model to free inpatient beds. A 2024 CMS study found lower mortality rates for AHCaH patients compared with traditional inpatient care, alongside high patient satisfaction, fewer readmissions, and improved mobility. These outcomes highlight HaH's effectiveness in managing acute conditions while aligning with patient preferences for home recovery, supported by 24/7 oversight and multidisciplinary teams.

North America Hospital at Home Market Company Profiles

Some of the key players operating in the market include B Braun SE, Medtronic Plc, Air Liquide, Huma Therapeutics Limited, Doccla, LNA-Santé, Inhealthcare, Spirit Health Group Ltd, RIBERA SALUD, and Capio Sverige AB.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

North America Hospital at Home Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise